The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The chairman of an outside committee of medical experts that advises the Food and Drug Administration on drug-safety issues said Friday the agency’s own drug-safety oversight board needed to be more open and transparent. The chairman of the committee recommended that the FDA add new members to its oversight board.

Comments are closed.

Of Interest